丙戊酰胺抑制人环氧水解酶。
Valpromide inhibits human epoxide hydrolase.
作者信息
Pacifici G M, Franchi M, Bencini C, Rane A
出版信息
Br J Clin Pharmacol. 1986 Sep;22(3):269-74. doi: 10.1111/j.1365-2125.1986.tb02886.x.
Abstract
The effect of antipileptic drug valpromide (VPM) on the activity of epoxide hydrolase was studied in human adult and foetal liver, kidneys, lungs, intestine and in placenta. The activity of the epoxide hydrolase was measured with both styrene oxide and benzo(a)pyrene-4,5-oxide as substrates. VPM inhibited the epoxide hydrolase obtained from all organs studied. The degree of inhibition was independent of the substrate used. A lowering of the epoxide hydrolase activity by 50% was observed when the concentration of VPM was similar to that of the substrates. VPM competitively inhibited the activity of adult liver epoxide hydrolase with styrene oxide as substrate.
摘要
研究了抗癫痫药物丙戊酰胺（VPM）对成人及胎儿肝脏、肾脏、肺、肠道和胎盘环氧水解酶活性的影响。以氧化苯乙烯和苯并（a）芘-4,5-氧化物为底物测定环氧水解酶的活性。VPM抑制了所研究的所有器官中的环氧水解酶。抑制程度与所用底物无关。当VPM浓度与底物浓度相似时，环氧水解酶活性降低了50%。以氧化苯乙烯为底物时，VPM竞争性抑制成人肝脏环氧水解酶的活性。
相似文献
1
Valpromide inhibits human epoxide hydrolase.丙戊酰胺抑制人环氧水解酶。
Br J Clin Pharmacol. 1986 Sep;22(3):269-74. doi: 10.1111/j.1365-2125.1986.tb02886.x.
2
Inhibition of human liver microsomal epoxide hydrolase by valproate and valpromide: in vitro/in vivo correlation.丙戊酸盐和丙戊酰胺对人肝微粒体环氧化物水解酶的抑制作用：体内外相关性
Clin Pharmacol Ther. 1989 Jul;46(1):82-93. doi: 10.1038/clpt.1989.110.
3
Valpromide is a poor inhibitor of the cytosolic epoxide hydrolase.
Arch Toxicol. 1989;63(2):157-9. doi: 10.1007/BF00316440.
4
Interaction of valproic acid and some analogues with microsomal epoxide hydrolase.丙戊酸及一些类似物与微粒体环氧化物水解酶的相互作用。
Biochem Pharmacol. 1992 Feb 18;43(4):775-83. doi: 10.1016/0006-2952(92)90243-c.
5
Valpromide but not sodium hydrogen divalproate inhibits epoxide hydrolase in human liver.丙戊酰胺而非丙戊酸钠抑制人肝脏中的环氧化物水解酶。
Pharmacol Toxicol. 1987 Mar;60(3):237-8. doi: 10.1111/j.1600-0773.1987.tb01743.x.
6
Heterologous expression of human microsomal epoxide hydrolase in Saccharomyces cerevisiae. Study of the valpromide-carbamazepine epoxide interaction.人微粒体环氧化物水解酶在酿酒酵母中的异源表达。丙戊酰胺 - 卡马西平环氧化物相互作用的研究。
Biochem Pharmacol. 1991 Sep 12;42(7):1367-72. doi: 10.1016/0006-2952(91)90447-d.
7
Kinetics of the inhibition of styrene oxide and benzo(a)pyrene-4,5-oxide hydration in rat liver microsomes by cadmium.镉对大鼠肝微粒体中环氧苯乙烯和苯并(a)芘-4,5-氧化物水化作用的抑制动力学
Biochim Biophys Acta. 1980 Aug 7;614(2):625-8. doi: 10.1016/0005-2744(80)90252-1.
8
Epoxide hydrolase in human fetal liver.人类胎儿肝脏中的环氧水解酶
Pharmacology. 1983;26(5):241-8. doi: 10.1159/000137807.
9
Multiple epoxide hydrolases in human lung.人类肺部中的多种环氧化物水解酶
Drug Metab Dispos. 1986 Mar-Apr;14(2):208-13.
10
Epoxide hydrolase in human placenta at different stages of pregnancy.孕期不同阶段人胎盘中的环氧水解酶
Dev Pharmacol Ther. 1983;6(2):83-93. doi: 10.1159/000457282.
引用本文的文献
1
Clinically significant pharmacokinetic drug interactions with carbamazepine. An update.卡马西平具有临床意义的药代动力学药物相互作用。最新进展。
Clin Pharmacokinet. 1996 Sep;31(3):198-214. doi: 10.2165/00003088-199631030-00004.
2
Effect of valpromide on the pharmacokinetics of carbamazepine-10, 11-epoxide.丙戊酰胺对卡马西平-10,11-环氧化物药代动力学的影响。
Br J Clin Pharmacol. 1988 May;25(5):611-3. doi: 10.1111/j.1365-2125.1988.tb03354.x.
3
Biochemical relationships between Reye's and Reye's-like metabolic and toxicological syndromes.瑞氏综合征及类瑞氏代谢与毒理学综合征之间的生化关系。
Med Toxicol Adverse Drug Exp. 1989 Jul-Aug;4(4):272-94. doi: 10.1007/BF03259913.
4
Valpromide is a poor inhibitor of the cytosolic epoxide hydrolase.
Arch Toxicol. 1989;63(2):157-9. doi: 10.1007/BF00316440.
5
Clinical pharmacology of valpromide.
Clin Pharmacokinet. 1991 Feb;20(2):114-22. doi: 10.2165/00003088-199120020-00003.
本文引用的文献
1
Protein measurement with the Folin phenol reagent.使用福林酚试剂进行蛋白质测定。
J Biol Chem. 1951 Nov;193(1):265-75.
2
Biosynthesis of 16 alpha, 17 alpha-epoxy-4-androsten-3-one in rat liver microsomes.大鼠肝微粒体中16α,17α-环氧-4-雄烯-3-酮的生物合成
Acta Endocrinol (Copenh). 1980 Sep;95(1):58-66.
3
Tissue and species differences in enzymes of epoxide metabolism.环氧化物代谢酶的组织和物种差异。
Xenobiotica. 1981 Feb;11(2):73-9. doi: 10.3109/00498258109045276.
4
5 alpha,6 alpha-Epoxy-cholestan-3 beta-ol (cholesterol alpha-oxide): A specific substrate for rat liver glutathione transferase B.
FEBS Lett. 1982 Dec 27;150(2):499-502. doi: 10.1016/0014-5793(82)80798-9.
5
Endogenous role of microsomal epoxide hydrolase. Ontogenesis, induction inhibition, tissue distribution, immunological behaviour and purification of microsomal epoxide hydrolase with 16 alpha, 17 alpha-epoxyandrostene-3-one as substrate.微粒体环氧化物水解酶的内源性作用。以16α,17α-环氧雄甾烯-3-酮为底物时微粒体环氧化物水解酶的个体发生、诱导抑制、组织分布、免疫行为及纯化。
Eur J Biochem. 1982 Aug;126(2):425-31.
6
Dipropylacetic acid plasma levels; diurnal fluctuations during chronic treatment with dipropylacetamide.
Ther Drug Monit. 1981;3(3):297-301. doi: 10.1097/00007691-198103000-00012.
7
Nuclear epoxide hydrolase in the human fetal and adult liver.
Pharmacology. 1984;28(6):321-8. doi: 10.1159/000137980.
8
Teratogenicity of antiepileptic drug combinations with special emphasis on epoxidation (of carbamazepine).抗癫痫药物联合使用的致畸性，特别强调（卡马西平的）环氧化作用。
Epilepsia. 1984 Feb;25(1):77-83. doi: 10.1111/j.1528-1157.1984.tb04158.x.
9
Human fetal liver cultures: basal activities and inducibility of epoxide hydrolases and aryl hydrocarbon hydroxylase.人胎儿肝脏培养物：环氧水解酶和芳烃羟化酶的基础活性及诱导性。
Biochem Pharmacol. 1984 Jan 1;33(1):71-7. doi: 10.1016/0006-2952(84)90371-x.
10
Possible hazard of valpromide-carbamazepine combination therapy in epilepsy.丙戊酰胺-卡马西平联合治疗癫痫的潜在风险。
Lancet. 1984 Apr 7;1(8380):802. doi: 10.1016/s0140-6736(84)91325-4.
Zotero 插件